Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing (Q35966481)

11 August 2017

1 reference

title

Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing (English)

1 reference

11 August 2017

1 reference

Kerryn Lutchman Singh

series ordinal

1

1 reference

11 August 2017

Melanie Davies

series ordinal

2

1 reference

11 August 2017

Ratna Chatterjee

series ordinal

3

1 reference

11 August 2017

publication date

29 November 2004

1 reference

Human Reproduction Update

11 August 2017

published in

1 reference

11 August 2017

volume

11

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

69-89

1 reference

Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Long-term ovarian function in sheep after ovariectomy and transplantation of autografts stored at -196 C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ovarian tissue banking for cancer patients: reduction of post-transplantation ischaemic injury: intact ovary freezing and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Gynaecologic concerns for young women exposed to gonadotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ovarian reserve testing and the use of prognostic models in patients with subfertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Assessment of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

The endocrinology of the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Basal estradiol and follicle-stimulating hormone predict fecundity in women of advanced reproductive age undergoing ovulation induction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Early menopause in long-term survivors of cancer during adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Use of the Antral Follicle Count to Predict the Outcome of Assisted Reproductive Technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

State of the art in in-vitro oocyte maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Absence of gonadotropin-releasing hormone receptors in human gonadal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Is inhibin B a potential marker of gonadotoxicity in prepubertal children treated for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Predictive power of clomiphene citrate challenge test for failure of in vitro fertilization treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Falsely elevated follicle-stimulating hormone levels in women with regular menstrual cycles due to interference in immunoradiometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Poor response after hormonal stimulation for in vitro fertilization is not related to ovarian aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Antimüllerian hormone serum levels: a putative marker for ovarian aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Livebirth after orthotopic transplantation of cryopreserved ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Regulation of ovarian function: the role of anti-Müllerian hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Young age does not protect against the adverse effects of reduced ovarian reserve--an eight year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Human oocyte cryopreservation: new perspectives regarding oocyte survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

A model conforming the decline in follicle numbers to the age of menopause in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ovarian function preservation in the cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

The role of inhibin B as a basal determinant of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Angiogenesis in reproductive tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ovarian volume and antral follicle counts as indicators of menopausal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Long-term effects of adjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Evaluation of basal estradiol levels in assisted reproductive technology cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Counting the costs of treatment: the reproductive and gynaecological consequences of adjuvant therapy in young women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Quality of Life Across the Continuum of Breast Cancer Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Menopause and breast cancer: addressing the secondary health effects of adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Follicular status at the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Current perspective on primordial follicle cryopreservation and culture for reproductive medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Anti-Müllerian hormone and its role in ovarian function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Young low responders protected from untoward effects of reduced ovarian response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Interobserver variation in ovarian measurements using transvaginal sonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Antral follicle counting in predicting the retrieved oocyte number after ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

An immunoassay to detect human müllerian inhibiting substance in males and females during normal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Perifollicular blood flow Doppler indices, but not follicular pO2, pCO2, or pH, predict oocyte developmental competence in in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ultrasonography of the pelvic organs in prepubertal and postpubertal girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Why is breast-cancer mortality declining?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Germline stem cells and follicular renewal in the postnatal mammalian ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

The present and future role of three-dimensional ultrasound in assisted conception

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Predictors of IVF outcome by three-dimensional ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Intercycle variability of ovarian reserve tests: results of a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Value of elevated basal follicle-stimulating hormone levels and the differential diagnosis during the diagnostic subfertility work-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Assessment of ovarian reserve. Ovarian biopsy is not a valid method for the prediction of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/l

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Reduced Ovarian Function in Long-Term Survivors of Radiation- and Chemotherapy-Treated Childhood Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Assessment of ovarian reserve - is there a role for ovarian biopsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Assessment of ovarian reserve: is there still a role for ovarian biopsy in the light of new data?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

The role of ovarian volume in reproductive medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Live birth after ovarian tissue transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Early ovarian ageing: a hypothesis. What is early ovarian ageing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Inhibins and activins in human ovulation, conception and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ovarian reserve-drawing distinctions between the quality and numbers of oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Reproduction post-chemotherapy in young cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

The effects of radiotherapy and chemotherapy on female reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Basal concentrations of oestradiol may predict the outcome of in-vitro maturation in regularly menstruating women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Fertility and the impact of systemic therapy on hormonal status following treatment for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Premature menopause after cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Inverse effects of activin and inhibin on the synthesis and secretion of FSH and LH by ovine pituitary cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Effects of age on hormonal and ultrasound markers of ovarian reserve in Chinese women with proven fertility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Early ovarian ageing: a hypothesis. Detection and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Side Effects of Adjuvant Endocrine Treatment in Premenopausal Breast Cancer Patients: A Prospective Randomized Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Embryo development after heterotopic transplantation of cryopreserved ovarian tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

21 January 2018

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ovarian volume related to age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Number and size of antral follicles as predictive factors in vitro fertilization and embryo transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Human ovarian tissue cryopreservation: indications and feasibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Fertility options for female cancer patients: facts and fiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Simultaneous evaluation of basal follicle-stimulating hormone and 17 beta-estradiol response to gonadotropin-releasing hormone analogue stimulation: an improved predictor of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Simultaneous evaluation of basal FSH and oestradiol response to GnRH analogue (F-G-test) allows effective drug regimen selection for IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Dynamic assays of inhibin B and oestradiol following buserelin acetate administration as predictors of ovarian response in IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ovarian tissue banking for cancer patients: is ovarian cortex cryopreservation presently justified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ovarian function following marrow transplantation for aplastic anemia or leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Quantitative transvaginal two- and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Psychosocial aspects of infertility and decisions about reproduction in young cancer survivors: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Having children after cancer. A pilot survey of survivors' attitudes and experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Assessment of ovarian reserve. Is there still a role for ovarian biopsy? First do no harm!

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Fertility preservation in female patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Genetic and functional analyses of polymorphisms in the human FSH receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Disappearing ovarian follicles and reproductive ageing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

The variability of female reproductive ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Developmental and endocrine aspects of normal ovarian aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ovarian follicle counts--not as simple as 1, 2, 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Prognostic factors in controlled ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Correlation between serum inhibin B and other indicators of the ovarian function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Age = egg quality, FSH level = egg quantity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Inhibins and activins: clinical advances in reproductive medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Oocyte freezing: here to stay?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-r

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/HUMUPD/DMH052

21 January 2018

Identifiers

DOI

10.1093/HUMUPD/DMH052

1 reference

11 August 2017

1 reference